Further assessment of GILZ levels in splenic resDCs revealed no differences between tumor-bearing and control mice, suggesting that the differences observed in TDLNs did not reflect a systemic modulation of GILZ levels in resDC subsets (Figure 8c and Supplemental Figure S7b). This evidence concerns the gene TSC22D3 and neoplasm.